Amanote Research
Register
Sign In
Patients With Laron Syndrome Are Protected From Development of Cancer Even if Treated With IGF-I
Reviews in Endocrinology and Metabolism
doi 10.11138/rem/2013.1.2.080
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2013
Authors
Z Laron
Publisher
CIC Edizioni Internazionali
Related search
The Insulin-Likegrowth Factor-1 (Igf I) Gene Is Expressed in Skin Fibroblasts From Children With Laron Growth Hormone (Gh) Insensitivity
Pediatric Research
Child Health
Pediatrics
Perinatology
SHORT TERM METABOLIC CHANGES AND LONG TERM RESPONSE TO RECOMBINANT IGF-I (rhIGF-I) THERAPY IN a NORTH AMERICAN CHILD WITH GH INSENSITIVITY (GHIS; LARON SYNDROME)
Pediatric Research
Child Health
Pediatrics
Perinatology
Patients With Breast Cancer Who Are Treated With Chemotherapy Risk Long-Term Nerve Damage
Cancer
Cancer Research
Oncology
How Protected Are Populations if Transmission Relapses? Insights From Mathematical Modeling and Simulation
Malaria Journal
Parasitology
Infectious Diseases
Prognostic Importance of PTEN, EGFR, HER-2, and IGF-1R in Gastric Cancer Patients Treated With Postoperative Chemoradiation
Turkish Journal of Medical Sciences
Medicine
Development of Double Cancer in Small Cell Lung Cancer Patients Treated With Intensive Chemotherapy
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Risk Factors for Development of Hypocalcemia in Patients With Cancer Treated With Bone-Modifying Agents
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Endocrinological Studies in Patients With Klinefelter's Syndrome Treated With Clomiphene
Reproduction
Cell Biology
Gynecology
Endocrinology
Reproductive Medicine
Obstetrics
Embryology
Ipratropium Bromide: Are Patients Treated With Optimal Therapy?
Postgraduate Medical Journal
Medicine
